Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial).

Mauri, Laura; Leon, Martin B; Yeung, Alan C; Negoita, Manuela; Keyes, Michelle J; Massaro, Joseph M

Mauri, Laura; Leon, Martin B; Yeung, Alan C; Negoita, Manuela; Keyes, Michelle J; Massaro, Joseph M.

Affiliation

Mauri L; Brigham and Women's Hospital, Boston, MA 02115, USA. lmauri1@partners.org

Am Heart J ; 161(5): 807-14, 2011 May.

Article in En | MEDLINE | ID: mdl-21570508

Subject(s)

Angioplasty, Balloon, Coronary/methods; Coronary Artery Disease/surgery; Drug-Eluting Stents; Sirolimus/analogs & derivatives; Coronary Angiography; Coronary Artery Disease/diagnostic imaging; Follow-Up Studies; Humans; Prospective Studies; Prosthesis Design; Sirolimus/pharmacology; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Coronary Artery Disease / Angioplasty, Balloon, Coronary / Sirolimus / Drug-Eluting Stents Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Am Heart J Year: 2011 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google